Towa Pharmaceutical Co Ltd
TSE:4553
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Towa Pharmaceutical Co Ltd
TSE:4553
|
JP |
|
S
|
Southern Copper Corp
DUS:PCU
|
US |
|
Zhejiang Publishing & Media Co Ltd
SSE:601921
|
CN |
|
L
|
LCC Infotech Ltd
NSE:LCCINFOTEC
|
IN |
|
R
|
Ryvu Therapeutics SA
WSE:RVU
|
PL |
|
Irisity AB (publ)
F:69M
|
SE |
|
L
|
Lexington Biosciences Holdings Corp
OTC:LXGTF
|
CA |
|
I
|
International Business Machines Corp
SGO:IBM
|
US |
|
Resimac Group Ltd
ASX:RMC
|
AU |
|
H
|
Hanryu Holdings Inc
NASDAQ:HRYU
|
KR |
|
A
|
Addi Industries Ltd
BSE:507852
|
IN |
|
Spring Real Estate Investment Trust
HKEX:1426
|
HK |
|
N
|
Nuscale Power Corp
NYSE:SMR
|
US |
|
M
|
Marblegate Acquisition Corp
NASDAQ:GATE
|
US |
|
Isetan Mitsukoshi Holdings Ltd
TSE:3099
|
JP |
|
F
|
FGI Industries Ltd
NASDAQ:FGI
|
US |
|
V
|
Vietnam National Reinsurance Corp
VN:VNR
|
VN |
|
Can2 Termik AS
IST:CANTE.E
|
TR |
|
S
|
Sun Yad Construction Co Ltd
TWSE:1316
|
TW |
|
A
|
Amazon.com Inc
XHAM:AMZ
|
US |
|
B
|
Bengal Tea & Fabrics Ltd
BSE:532230
|
IN |
|
Siam Cement PCL
SET:SCC
|
TH |
|
Yokogawa Electric Corp
TSE:6841
|
JP |
|
King Slide Works Co Ltd
TWSE:2059
|
TW |
Multiples-Based Value
The Multiples-Based Value of one
Towa Pharmaceutical Co Ltd
stock under the Base Case scenario is
hidden
JPY.
Compared to the current market price of 4 235 JPY,
Towa Pharmaceutical Co Ltd
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
Towa Pharmaceutical Co Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| JP |
|
Towa Pharmaceutical Co Ltd
TSE:4553
|
208.5B JPY | 0.8 | 9.7 | 8.1 | 15.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
879.7B USD | 13.5 | 42.6 | 28.8 | 30.7 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.1B USD | 6.1 | 21.4 | 14.9 | 18.3 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.7 | 11.6 | 13.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
232B GBP | 5.2 | 30 | 16.6 | 23.4 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.2B USD | 4.5 | 16.2 | 10 | 12.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF | 5.1 | 20.7 | 12.8 | 16.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.2 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.1B USD | 2.5 | 19.8 | 7.6 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
116.1B USD | 2.4 | 16.5 | 7 | 8.6 |